Surgical strategy of bilateral synchronous sporadic renal cell carcinoma—experience of a Chinese university hospital by unknown
RESEARCH Open Access
Surgical strategy of bilateral synchronous
sporadic renal cell carcinoma—experience
of a Chinese university hospital
Xiao-Yi Hu†, Lei Xu†, Jian-Ming Guo* and Hang Wang*
Abstract
Background: The objective of this study is to investigate the optimal therapeutic protocol for BSSRCC.
Methods: A total of 32 BSSRCC patients, including 28 males and 4 females, were enrolled the study from January 2004
to May 2016. The diagnoses were defined by the measurements of CT, ultrasound, and MRI. Patients with hereditary
syndrome were excluded. The management of surgical manner, operation staging, and sequence were scheduled in
accordance with the tumor’s location and size (based on Zhongshan score, ZS score), as well as the performance status
of the patients. Among them, 8 cases were conducted with bilateral surgical procedure simultaneously and 24 cases
were implemented with staged operations. NSS on the one side with contralateral RN, and NSS on both sides were
performed in 17 and 15 patients separately.
Results: Thirty cases were conducted 56 operations in total. The average operation time was 260 ± 52 min in
simultaneous operations and 162 ± 40 min in staged operations. The length of hospital stay in average was 11.
5 ± 1.8 and 7.5 ± 1.4 days, respectively. Twenty-eight cases were followed up by 6–138 months. The level of
creatinine was elevated in 5 cases without hemodialysis conducted.
Conclusions: The location and size of the carcinomas, and the performance status of patients should be considered
in determination of an appropriate surgical approach. Both renal function preservation and tumor eradication were
similarly critical, whereas the latter is of more importance. ZS score may be helpful in the dilemma. Longer follow-up
period and more patient enrolment are required.
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Background
Bilateral synchronous sporadic renal cell carcinoma
(BSSRCC) is an uncommon disease accounting for
3~4.2% renal carcinomas [1, 2]. It is a difficult surgical
dilemma for the urologist to formulate the therapeutic
strategy for individual patient. Previous study disclosed
patients with this type of tumor usually demonstrated a
poor prognosis [3]. As usual, bilateral radical nephrec-
tomy (RN) followed by renal replacement was the major
management to these patients, which can obtain a 71%
5-year survival in patients undergoing hemodialysis and
86% 5-year survival in patients receiving kidney trans-
plantation [4]. However, increasing evidences in a variety
of studies [5–7] suggested the favorable outcomes of the
disease recently. Surgical resection may provide the lon-
ger beneficial effect of cancer control for patients treated
by bilateral RCC, with similar survival between syn-
chronous and metachronous cancers. Meanwhile, the
prognosis between the patients with N0M0 synchronous
bilateral RCC and the patients with N0M0 unilateral
RCC are comparable. Singer et al. [5] reported that the
overall survival (OS) was 88% in the patients with syn-
chronous sporadic carcinomas in a median 16-year
follow-up period, which indicated the nephron-sparing
surgery (NSS) was an essential procedure to bilateral
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made during operation, so as to protect the renal func-
tion. In the present study, we summarize the experience
in the treatment of the BSSRCC and suggest the selec-
tion criteria of the surgical manner.
Methods
Patients’ characteristics
A total of 32 BSSRCC patients, including 28 males and
4 females at Zhongshan Hospital, Fudan University,
were enrolled in the study between January 2004 and
May 2016. The study was a prospective design, and the
data were collected into an institutional review board-
approved database. The patients with bilateral metachro-
nous renal tumors, cystic renal masses, familial renal cell
carcinoma syndromes, urothelial cell carcinomas, and de-
fined hereditary syndromes were excluded in accordance
with the diagnosis criteria [8]. ECOG PS of all the patients
were 0~2.
Among all patients, 22 cases were clued unexpectedly
in an annual routine physical examination, 5 cases were
diagnosed with major complaint of flank pain in clinic
and 5 cases were defined due to hematuria. All diagno-
ses were established depending on the evidence of bilat-
eral renal masses on ultrasound and CT imagings before
surgery. Intravenous urography (IVU) was adopted in 12
cases, in which 10 were identified with the compression
of unilateral or bilateral renal pelvis or calyx. MRI dem-
onstrated the bilateral renal masses in all 14 patients.
Cancer embolus in the vena cava was detected in one
patient and megatherium lymph nodes in the retroperi-
toneum were found in another patient. None of patients
showed the signs of distant metastasis. According to the
2009 UICC/AJCC TNM staging system, 44 (68.8%) tu-
mors were classified at T1aN0M0, 13 (20.3%) tumors
were at T1bN0M0, 5 (7.8%) tumors were at T2N0M0, 1
(1.6%) tumor was at T3bN0M0, and other 1 (1.6%)
tumor was at T2N1M0 (Table 1).
All tumors were stratified into three complexity levels
according to Zhongshan score (ZS score) [9]. Low-risk
tumors were scored between 3~4, whereas moderate
tumors were scored between 5~7, and high-risk tumors
were scored ≥8.
Preoperative work-up
The preoperative work-up consists of medical history,
physical examinations, and routine laboratory tests. Con-
centrations of serum creatinine were recorded before
and after operation consecutively at an interval of 3–
6 months. Estimated Glomerular filtration rate (GFR)
was calculated using the modification of diet in renal
disease (MDRD) formula. Postoperative assessments
during follow-up period included abdominal ultrasonog-
raphy and chest x-ray examinations at the interval of
each 3 months in the first 2 years and at each 6 months
afterward.
Treatment
One-stage bilateral surgery was performed in eight
patients, of which six cases were carried out bilateral
NSS and two cases were taken RN for one side first
and NSS for the opposite side thereafter. Two-stage
operations were performed in other 24 cases, of
which 5 cases were adopted NSS first and RN for the
opposite side 4–8 weeks later; 10 cases were per-
formed RN first and then NSS for the opposite side
4–8 weeks later; 9 cases were conducted NSS in both
sides within 4–8 weeks. For one patient with tumor
embolus in vena cava, an intravenous stent was
placed and a filter was positioned at inferior vena
cava before operation to prevent the embolus occlu-
sion, followed by ipsilateral RN and contralateral NSS
Table 1 Baseline demographic and clinical characteristics of the
BSSRCC patients










TNM stage Right side, N = 32 Left side, N = 32
T1aN0M0 21 (65.6%) 23 (71.8%)
T1bN0M0 9 (28.1%) 4 (12.5%)
T2aN0M0 1 (3.1%) 1 (3.1%)
T2bN0M0 0 3 (9.4%)
T3bN0M0 1 (3.1%) 0
T2N1M0 0 1 (3.1%)
Operation Sequence N = 32 N = 32
First 12 (37.5%) 20 (62.5%)
Second 20 (62.5%) 12 (37.5%)
Operation methods N = 32 N = 32
NSS 24 (75.0%) 23 (71.9%)
RN 8 (25.0%) 9 (28.1%)
ZS score N = 24 N = 23
Low risk 5 (20.8%) 6 (26.1%)
Moderate 10 (41.6%) 8 (33.3%)
High risk 9 (37.5%) 9 (39.1%)
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7 weeks later. The characteristics of tumor size and the
therapeutic options are summarized in Table 1. Complica-
tions were evaluated using the Clavien scale [10].
Surgical strategy for BSSRCC
Selection of surgical stage
One-stage bilateral surgery (OBS): OBS is considered
when physical status of the patient is fitted (ECOG PS = 0)
while being without any comorbidity.
Two stages surgery (TSS): TSS is selected for the pa-
tient with large size tumor or other complications, such
as cancer embolus in the vena cava. Patients with ECOG
PS > 0 are also enrolled in this group.
Surgical sequence
For BSSRCC patients intending staged surgery, the choos-
ing of side to be operated initially and the surgical ap-
proach should be meticulously decided based on the
Fig. 1 Bilateral NSS: larger tumor on the left side was dissected first
Fig. 2 Bilateral NSS: larger tumor on the left side was dissected first (Figs. 1 and 2 were of the same patient)
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tumor location and size at both the kidneys. For the bilat-
eral NSS, first-stage surgery should be conducted on the
side with higher ZS score tumors (Figs. 1 and 2). For the
patients determined to do radical and partial resection
separately at both sides one after another, the first-stage
radical surgery should be operated on the side with larger
tumor as well, if the partial resection to low-moderate risk
tumors in the other side were easy to perform expectedly
(Figs. 3 and 4). However, if tumors were assessed at
high-risk level on the one side which were planned to
do partial resection, the NSS procedure should be op-
erated earlier than contralateral RN (Fig. 5). If NSS
was unsuccessful and required to switch to RN, fur-
ther preparations including appropriate hemodialysis
were necessary prior to the second-stage operation of
contralateral RN (Table 2).
Fig. 3 RN on the right side first and NSS on the left thereafter at second staged surgery
Fig. 4 RN on the right side first and NSS on the left thereafter at second staged surgery (Figs. 3 and 4 were of the same patient)
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The same criteria should be met in one-stage bilateral
surgery in management of surgical schedule.
Results
A total of 56 operations were productively completed in
all 32 patients (average age 54.7 years, range 31 to 77).
Surgical patterns of retroperitoneal open partial nephrec-
tomy (OPN) and transperitoneal open/laparoscopic rad-
ical nephrectomy were selectively applied. Mean operation
time of OBS and TSS were 263 ± 50 min (range 200–320)
and 154 ± 42 min (range105–180), mean hospitalization
time of OBS and TSS were 11.4 ± 1.9 days (range 8–15)
and 7.4 ± 1.3 days (range 6–9), respectively. The warm is-
chemia time in NSS was 26 ± 7 min (range 16–45). Patho-
logical examination of 64 neoplasms samples revealed that
57 samples were clear cell carcinoma, 5 were papillary car-
cinoma, and 2 were chromophobe carcinoma.
After bilateral NSS, one patient appeared pseudoaneur-
ysm of renal arteriole, accompanied with gross hematuria
and hypovolemic shock. The patient then received the
treatment of percutaneous high-selective renal arterial
embolization (Clavien grade 3). Twenty-eight patients were
followed up 6–138 months (median 89 months) except four
patients were lost contact. The renal function was main-
tained in normal range in 23 patients. Increased cre-
atinine (125–187 μmol/L) level and reduced eGFR were
happened in five patients, who were treated with NSS
on the one side and contralateral RN without
hemodialysis. Lung metastasis was found in one patient
after 14 months of RN plus contralateral NSS operation
and died 25 months later. Tumor recurrence at the left
nephridial pit was seen in one patient conducted with
NSS on the both sides. The patient was treated with sal-
vage radiotherapy and died 38 months later after surgery.
One patient with RN and contralateral NSS died from
cerebrovascular accident 6 months after surgery (Table 3).
Discussion
Although BSSRCC is an uncommon disease with lower
incidence [11], the management is much more difficult
Fig. 5 NSS on the left side first and RN on the right side at second staged surgey
Table 2 Surgical sequence of the BSSRCC based on ZS score
First step Second step
Bilateral NSS Higher risk side Lower risk side
RN+NSS RN NSS (low-moderate risk)
NSS (high risk) RN
Table 3 Results of following up of the BSSRCC patients
Characteristics Number(percentage)
Lost in follow-up 4 (12.5%)
Complications
Clavien I~II 5 (17.9%)
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and complicated than that of metachronous RCC.
Accordingly, the selection of surgical approach and
the schedule of operation sequence require careful
evaluation of the disease and the general condition
of patients.
Surgical criteria
Selection of operation pattern in our study
1). Bilateral NSS: The location and size of the tumor in
both sides meet the indication for NSS (Fig. 6). In
present series, 15 patients were implemented
bilateral NSS.
2). Lateral NSS on the one side and RN on the
contralateral side. In general, it was applied for
patients with small tumor on the one side which
meet the indication for NSS and with relatively
larger tumor on the other side which required RN.
Seventeen patients in the cohort received surgery
in this manner (Fig. 7). Four patients showed the
elevation of creatinine levels after operation
because of inadequate preservation of renal
parenchyma. It indicated the renal parenchyma
should be conserved as much as possible in NSS
to avoid postoperative dialysis.
3). Bilateral RN. It is applied in patients with bilateral
large tumors which are unsuitable for NSS. Due
to the complete loss of renal function after
surgery, kidney replacements are necessary to
maintain the life of patients. Therefore, the
selection of this surgical manner should be
particularly cautious. None of our patient has
taken this surgical manner.
Surgery sequence
The individual therapeutic protocol for each patient
should be created only through appropriately weighing
the advantages and disadvantages of different surgical
sequences, then make the selection of either one-stage
or two-stage surgery manner and which side is the first
for surgery. The essential principle is which manner can
provide the optimal effects of thoroughly eliminating the
tumor cells as early as possible. One-stage bilateral sur-
gery may be the effective therapeutic method for
BSSRCC based on the criteria in case of physical status
of the patient allowed. However, the elderly patients or
those with vital organ dysfunction owing to compli-
cated status of operation either in one or two sides is
better to take staged surgery after 1–2 months of the
first-stage surgery done. The initial operation on one
side is a pivotal procedure in staged surgery. We should
focus on the high risk tumor of BSSRCC following the
above criteria. But it is not always the case. Maximal
preservation of renal function should be taken into ac-
count at the same time, especially in the case of NSS
with contralateral RN. Consequently, we describe the
therapeutic methods in combination of renal function
preservation and tumor removal in making our surgical
criteria.
In summary, both preservation of the renal paren-
chyma and tumor eradication should be considered
simultaneously in management of BSSRCC. Before
formulating an individual therapeutic regime, the pa-
tient’s performance status, tumor size, and location
should be evaluated carefully [12] according to the ZS
score. The renal parenchyma should be preserved as
much as possible during the operation to prevent
Fig. 6 Left central renal tumor was partially resected
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hemodialysis postoperatively, but complete tumor re-
moval is the most important target for the treatment
of patient.
Our newly established surgical criteria for BSSRCC,
using our novel and simple score system, have demon-
strated encouraging and satisfactory outcomes (Fig. 8). It
is feasible and safe in clinical application. Since BSSRCC
is a rare disease [13, 14], the longer follow- up period,
more patient enrolment, and novel anatomic classifica-
tion systems [15] are needed to further investigate the
beneficial effects of different surgical approaches for
the patients.
Conclusions
We established our promising surgical criteria for BSSRCC
based on the ZS score.
Both preservation of renal parenchyma and tumor
eradication should be considered in BSSRCC. Before for-
mulating a therapeutic regime, the patient’s performance
status, tumor size, and location should be evaluated.
Renal parenchyma should be preserved as much as pos-
sible during the operation, but complete tumor removal
is more important.
Longer follow-up and more patients enrolment are
required.
Fig. 8 One year after bilateral NSS with normal renal function and no tumor recurrence could be found
Fig. 7 NSS on the right side and RN on the left
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